Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04180163
Recruitment Status : Completed
First Posted : November 27, 2019
Last Update Posted : September 29, 2021
Sponsor:
Information provided by (Responsible Party):
Takeda ( Shire )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 26, 2021
Actual Study Completion Date : August 26, 2021